Cite
MLA Citation
C. Schwabe et al.. “FRI0168 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BI 655064, An Antagonistic Anti-CD40 Antibody in Healthy Volunteers.” Annals of the rheumatic diseases, vol. 74, n.d., p. 484. http://access.bl.uk/ark:/81055/vdc_100135149059.0x000053